Protein Kinase Inhibitor Enhances Low-Affinity T-Cell Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting T-cells using pMHC tetramers are limited in detecting cells with low affinity TCRs, leading to incomplete identification of tumor-specific or autoreactive T-cells, as they require high affinity interactions for effective staining and visualization.
Innovation Solution
The use of a protein kinase inhibitor (PKI) enhances pMHC tetramer staining by preventing receptor internalization and recycling, thereby increasing the availability of TCRs on the cell surface for detection, allowing for the visualization of T-cells with low affinity TCRs that would otherwise be undetectable.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If pMHC tetramer staining is used to detect T-cells, then detection of high affinity TCRs is achieved, but detection of low affinity TCRs fails
Solution Approach 1:
The patent applies parameter changes by modifying the biochemical environment through protein kinase inhibition. By inhibiting protein kinase activity, the system changes the phosphorylation state of TCR complex components, which enhances the binding affinity between low-affinity TCRs and pMHC tetramers, thereby expanding the detection range to include low affinity TCRs while maintaining high affinity detection
2Measurement precision
If protein kinase inhibitor is used to enhance low affinity TCR detection, then detection sensitivity for low affinity TCRs improves, but assay complexity increases
Solution Approach 1:
The patent uses a protein kinase inhibitor as an intermediary substance to mediate between the TCR-pMHC interaction and the detection system. The inhibitor acts as a chemical mediator that modifies the TCR complex state, enabling enhanced binding without requiring complex instrumental modifications or multi-step procedural changes to the assay
3Reliability
If conventional staining procedures are used, then high affinity TCR detection is maintained, but reagent consumption increases
Solution Approach 1:
By changing the biochemical parameters through protein kinase inhibition, the system achieves enhanced binding affinity that allows detection with lower reagent concentrations. This parameter modification enables the same detection reliability to be achieved with reduced pMHC tetramer and antibody concentrations, thereby conserving reagents
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The PKI treatment significantly enhances the detection of antigen-specific T-cells with low avidity TCRs, reduces tetramer-induced cell death, and conserves reagents, enabling the identification of previously undetectable T-cells while maintaining specificity to cognate TCRs.
Implementation Method 1
Protein kinases are enzymes that modify other proteins by chemically adding phosphate groups to them (phosphorylation). This involves the removal of a phosphate group from ATP and covalently attaching it to one of three-amino acids that have a free hydroxyl group.
Implementation Method 2
T-cells detect antigens in the form of peptides bound to major histocompatibility complex (MHC) molecules at the cell surface. This primary recognition event enables the orchestration of adaptive immunity and targeted destruction of transformed and pathogen-infected cells.
Data Source
AI summary
The invention relates to a method for sorting, staining or detecting T cells of the immune system using a protein kinase inhibitor.